How do pre-AIA notions of obviousness apply under the AIA?
Generally, pre-AIA notions of obviousness continue to apply under the AIA, with some exceptions. The MPEP states: “Generally speaking, and with the exceptions noted herein, pre-AIA notions of obviousness continue to apply under the AIA.“ This means that many of the established principles and case law regarding obviousness determinations remain relevant under the AIA. However,…
Read MoreWhat is the significance of the effective filing date in AIA 35 U.S.C. 103?
The effective filing date plays a crucial role in determining the applicable version of 35 U.S.C. 103 and the scope of prior art for obviousness rejections. According to MPEP 2158: “The changes to 35 U.S.C. 102 and 103 in the AIA do not apply to any application filed before March 16, 2013. Thus, any application…
Read MoreWhat is the main difference between AIA 35 U.S.C. 103 and pre-AIA 35 U.S.C. 103?
The most significant difference between AIA 35 U.S.C. 103 and pre-AIA 35 U.S.C. 103(a) is the timing of the obviousness determination. As stated in the MPEP: “AIA 35 U.S.C. 103 determines obviousness before the effective filing date of the claimed invention, rather than as of the time that the claimed invention was made.“ This change…
Read MoreHow does AIA 35 U.S.C. 103 differ in terminology from pre-AIA 35 U.S.C. 103?
AIA 35 U.S.C. 103 uses slightly different terminology compared to pre-AIA 35 U.S.C. 103, but this change does not affect the approach to determining obviousness. The MPEP states: “AIA 35 U.S.C. 103 requires consideration of ‘the differences between the claimed invention and the prior art,’ while pre-AIA 35 U.S.C. 103 refers to ‘the differences between…
Read MoreWhat is the impact of AIA 35 U.S.C. 103 on the scope of prior art?
AIA 35 U.S.C. 103 has significantly expanded the scope of prior art that can be used in obviousness rejections. The MPEP 2158 explains: “AIA 35 U.S.C. 103 differs from pre-AIA 35 U.S.C. 103(a) in that AIA 35 U.S.C. 103 determines obviousness as of the effective filing date of the claimed invention, rather than as of…
Read MoreHow does AIA 35 U.S.C. 103 define prior art for obviousness determinations?
AIA 35 U.S.C. 103 relies on AIA 35 U.S.C. 102(a) to define prior art for both novelty and obviousness determinations. The MPEP states: “AIA 35 U.S.C. 102(a) defines what is prior art both for purposes of novelty under AIA 35 U.S.C. 102 as well as for purposes of obviousness under AIA 35 U.S.C. 103.“ This…
Read MoreHow does AIA 35 U.S.C. 103 affect the determination of obviousness?
AIA 35 U.S.C. 103 has modified the determination of obviousness in patent examination. The key changes include: Elimination of pre-AIA 35 U.S.C. 103(c), which provided a safe harbor for commonly owned prior art or prior art resulting from a joint research agreement. Introduction of a new prior art exception under AIA 35 U.S.C. 102(b)(2)(C) for…
Read MoreHow does AIA 35 U.S.C. 103 treat commonly owned prior art?
AIA 35 U.S.C. 103 has changed the treatment of commonly owned prior art in obviousness determinations. The MPEP 2158 states: “The AIA eliminated the pre-AIA 35 U.S.C. 103(c) safe harbor for subject matter commonly owned or subject to an obligation of assignment to the same person at the time the claimed invention was made.” Instead,…
Read MoreWhat changes did AIA 35 U.S.C. 103 make to pre-AIA 35 U.S.C. 103(b) and 103(c)?
AIA 35 U.S.C. 103 made significant changes to pre-AIA 35 U.S.C. 103(b) and 103(c): Pre-AIA 35 U.S.C. 103(b): This provision, which applied to biotechnological inventions, has been eliminated in AIA 35 U.S.C. 103. Pre-AIA 35 U.S.C. 103(c): This has been eliminated, but similar provisions have been introduced in AIA 35 U.S.C. 102(b)(2)(C) and 102(c). The…
Read More